Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.
about
Combination therapy for extensively-drug resistant gram-negative bacteria.Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens.In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae.Synergistic Activity of Colistin/Fosfomycin Combination against Carbapenemase-Producing Klebsiella pneumoniae in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
P2860
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pharmacodynamics of colistin a ...... oducing Klebsiella pneumoniae.
@en
type
label
Pharmacodynamics of colistin a ...... oducing Klebsiella pneumoniae.
@en
prefLabel
Pharmacodynamics of colistin a ...... oducing Klebsiella pneumoniae.
@en
P2093
P2860
P50
P356
P1476
Pharmacodynamics of colistin a ...... oducing Klebsiella pneumoniae.
@en
P2093
Amanda Marrocco
Barry N Kreiswirth
Brian T Tsuji
Jing Zhang
Michael J Satlin
Phillip J Bergen
Thomas J Walsh
P2860
P304
P356
10.1093/JAC/DKX070
P407
P577
2017-07-01T00:00:00Z